ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

Cramer, Paige E., Cirrito, John R., Wesson, Daniel W., Lee, C. Y. Daniel, Karlo, J. Colleen, Zinn, Adriana E., Casali, Brad T., Restivo, Jessica L. +5 more·2012·Science

DOI 10.1126/science.1217697

Cited by (1,000)

Items 601–700 of 1,000

Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis
Mahsa Motavaf, Majid Sadeghizadeh, Mohammad Javan · 2017 · Cellular and Molecular Neurobiology
Nuclear Localization of Apolipoprotein E4: A New Trick for an Old Protein
Rohn, Troy T · 2017 · International Journal of Neurology and Neurotherapy
Bexarotene, a Selective RXRα Agonist, Reverses Hypotension Associated with Inflammation and Tissue Injury in a Rat Model of Septic Shock
Bahar Tunçtan, Sefika Pinar Kucukkavruk, Meryem Temiz-Reşitoğlu, Demet Sinem Güden, Ayse Nihal Sari, Seyhan Şahan-Fırat · 2017 · Inflammation
The Current Challenges for Drug Discovery in CNS Remyelination
Sonia Balestri, Alice Del Giovane, Carola Sposato, Marta Ferrarelli, Antonella Ragnini‐Wilson · 2021 · International Journal of Molecular Sciences
Challenges in Designing Therapeutic Agents for Treating Alzheimer’s Disease-from Serendipity to Rationality
Umer Rashid, Farzana Latif Ansari · 2014 · Elsevier eBooks
Rodent Modeling of Alzheimer's Disease in Down Syndrome: In vivo and ex vivo Approaches
Farrell, Clíona, Mumford, Paige, Wiseman, Frances K. · 2022 · Frontiers in Neuroscience
APOE polymorphism in ATTR amyloidosis patients treated with lipid nanoparticle siRNA
Niemietz, Christoph, Nadzemova, Oksana, Zibert, Andree, Schmidt, Hartmut H.-J. · 2020 · Amyloid
APOE and vascular disease: Sequencing and genotyping in general population cohorts
Rasmussen, Katrine L., Luo, Jiao, Nordestgaard, Børge G., Tybjærg-Hansen, Anne, Frikke-Schmidt, Ruth · 2023 · Atherosclerosis
Alzheimer's disease and Down's syndrome: Treating two paths to dementia
Marc E. Weksler, Paul Szabo, Norman R. Relkin, Marcus M. Reidenberg, Babette Barbash Weksler, Antonia M. W. Coppus · 2012 · Autoimmunity Reviews
Targeting Alzheimer's Pathology through PPARγ Signaling: Modulation of Microglial Function
Mychael V. Lourenco, José Henrique Ledo · 2013 · Journal of Neuroscience
Electron densities of bexarotene and disila-bexarotene from invariom application: a comparative study
Peter Luger, Manuela Weber, Christian B. Hübschle, Reinhold Tacke · 2013 · Organic & Biomolecular Chemistry
Bioactive Compound Screen for Pharmacological Enhancers of Apolipoprotein E in Primary Human Astrocytes
Gina M. Finan, Ronald B. Realubit, Sungkwon Chung, Dieter Lütjohann, Nan Wang, John R. Cirrito, Charles Karan, Taewan Kim · 2016 · Cell chemical biology
Substantial protection against MPTP-associated Parkinson's neurotoxicity in vitro and in vivo by anti-cancer agent SU4312 via activation of MEF2D and inhibition of MAO-B
Baojian Guo, Shengquan Hu, Chengyou Zheng, Hongyu Wang, Fangcheng Luo, Haitao Li, Wei Cui, Xifei Yang, Guozhen Cui, Shinghung Mak et al. · 2017 · Neuropharmacology
Molecular docking, dynamics, and pharmacology studies on bexarotene as an agonist of ligand‐activated transcription factors, retinoid X receptors
Nitin Chitranshi, Yogita Dheer, Sanjay Kumar, Stuart L. Graham, Vivek Gupta · 2019 · Journal of Cellular Biochemistry
Effects of DHA dietary intervention on hepatic lipid metabolism in apolipoprotein E-deficient and C57BL/6J wild-type mice
Jingjing Xu, Yujie Guo, Xiaochen Huang, Xiaojun Ma, Pengfei Li, Ying Wang, Xixiang Wang, Linhong Yuan · 2021 · Biomedicine & Pharmacotherapy
Treatment of Alzheimer's disease with small-molecule photosensitizers
Yefei Jiang, Zhiyong Zeng, Jianhua Yao, Ying Guan, Peipei Jia, Xiao‐Li Zhao, Lin Sen Xu · 2022 · Chinese Chemical Letters
Identifying genetic interactions associated with late-onset Alzheimer’s disease
Charalampos S. Floudas, Nara Um, M. Ilyas Kamboh, M. Michael Barmada, Shyam Visweswaran · 2014 · BioData Mining
Current status of myelin replacement therapies in multiple sclerosis
Jeffrey K. Huang, Robin J.M. Franklin · 2012 · Progress in brain research
Bexarotene Attenuates Focal Cerebral Ischemia–Reperfusion Injury via the Suppression of JNK/Caspase-3 Signaling Pathway
Hailin Liu, Shengwei Liu, Xiaocui Tian, Qian Wang, Jiangyan Rao, Yucun Wang, Fei Xiang, Hang Zheng, Lu Xu, Zhi Dong · 2019 · Neurochemical Research
APOE signaling in neurodegenerative diseases: an integrative approach targeting APOE coding and noncoding variants for disease intervention
Xiaopu Zhou, Amy K.Y. Fu, Nancy Y. Ip · 2021 · Current Opinion in Neurobiology
Cholinergic Modification of Neurogenesis and Gliosis Improves the Memory of AβPPswe/PSEN1dE9 Alzheimer’s Disease Model Mice Fed a High-Fat Diet
Takeshi Matsuda, Tatsuhiro Hisatsune · 2016 · Journal of Alzheimer s Disease
Retinoic acid in Parkinson's disease: Molecular insights, therapeutic advances, and future prospects
Ashutosh Pareek, Runjhun Singhal, Aaushi Pareek, Terisha Ghazi, Devesh U. Kapoor, Yashumati Ratan, Arun Kumar Singh, Vivek Jain, Anil Amichund Chuturgoon · 2024 · Life Sciences
Protective role of anticancer drugs in neurodegenerative disorders: A drug repurposing approach
Dia Advani, Rohan V. Gupta, Rahul S. Tripathi, Sudhanshu Sharma, Rashmi K. Ambasta, Pravir Kumar · 2020 · Neurochemistry International
Retinoid X receptor activation promotes re-myelination in a very old triple transgenic mouse model of Alzheimer’s disease
Daniel F. Santos-Gil, Gonzalo Arboleda, Adrián Gabriel Sandoval-Hernández · 2021 · Neuroscience Letters
Molecular Pathobiology of the Cerebrovasculature in Aging and in Alzheimers Disease Cases With Cerebral Amyloid Angiopathy
Joseph O. Ojo, Jon M. Reed, Gogce C. Crynen, Prashanthi Vallabhaneni, James Evans, Benjamin Shackleton, Maxwell Eisenbaum, Charis Ringland, Anastasia Edsell, MICHAEL J. MULLAN et al. · 2021 · Frontiers in Aging Neuroscience
Brain‐specific loss of Abcg1 disturbs cholesterol metabolism and aggravates pyroptosis and neurological deficits after traumatic brain injury
Heng Xu, Le‐xin Zheng, Xue‐Shi Chen, Qiuyu Pang, Ya'nan Yan, Rong Liu, Hanmu Guo, Zhiyang Ren, Yan Yang, Zhiya Gu et al. · 2022 · Brain Pathology
Regulation of beta‐amyloid for the treatment of Alzheimer's disease: Research progress of therapeutic strategies and bioactive compounds
Weimin Qiu, Hui Liu, Yijun Liu, Xin Lü, Lei Wang, Yanyu Hu, Feng Feng, Qi Li, Haopeng Sun · 2023 · Medicinal Research Reviews
Inhibition of ACAT as a Therapeutic Target for Alzheimer's Disease Is Independent of ApoE4 Lipidation
Ana Carolina Valencia‐Olvera, Deebika Balu, Naomi Faulk, Aspasia Amiridis, Yueting Wang, Christine Pham, Eva Avila-Munoz, Jason M. York, Gregory R. J. Thatcher, Mary Jo LaDu · 2023 · Neurotherapeutics
Chiral Dihydrobenzofuran Acids Show Potent Retinoid X Receptor–Nuclear Receptor Related 1 Protein Dimer Activation
Henrik Sundén, Anja Schäfer, Marcel Scheepstra, S. Leysen, Marcus Malo, Jian‐Nong Ma, Ethan S. Burstein, Christian Ottmann, Luc Brunsveld, Roger Olsson · 2016 · Journal of Medicinal Chemistry
Modeling, Synthesis, and Biological Evaluation of Potential Retinoid X Receptor (RXR)-Selective Agonists: Analogues of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(5,5,8,8-tetrahydronaphthalen-2-yl)amino)nicotinic Acid (NEt-TMN)
Michael C. Heck, Carl E. Wagner, Pritika H. Shahani, Mairi MacNeill, Aleksandra Grozić, Tamana Darwaiz, Micah Shimabuku, David G. Deans, Nathan M. Robinson, Samer H. Salama et al. · 2016 · Journal of Medicinal Chemistry
Differential Methylation in APOE (Chr19; Exon Four; from 44,909,188 to 44,909,373/hg38) and Increased Apolipoprotein E Plasma Levels in Subjects with Mild Cognitive Impairment
Oscar Mancera Páez, Kelly Estrada-Orozco, Maria Fernanda Mahecha, Francy Cruz Sanabria, Kely Johana Bonilla-Vargas, Nicolas Sandoval, Esneyder Guerrero, David Salcedo-Tacuma, Jesús D. Melgarejo, Edwin Vega et al. · 2019 · International Journal of Molecular Sciences
Brain Arrhythmias Induced by Amyloid Beta and Inflammation: Involvement in Alzheimer’s Disease and Other Inflammation-related Pathologies
Fernando Peña‐Ortega · 2019 · Current Alzheimer Research
An Overview of Several Inhibitors for Alzheimer’s Disease: Characterization and Failure
Subramanian Boopathi, Adolfo B. Poma, Ramón Garduño‐Juárez · 2021 · International Journal of Molecular Sciences
Cholestenoic acid, an endogenous cholesterol metabolite, is a potent γ-secretase modulator
Joo In Jung, Ashleigh R. Price, Thomas B. Ladd, Yong Ran, Hyo-Jin Park, Carolina Ceballos‐Diaz, Lisa A. Smithson, Günther Hochhaus, Yufei Tang, Rajender Akula et al. · 2015 · Molecular Neurodegeneration
Simple and sensitive HPLC-UV method for determination of bexarotene in rat plasma
Jong Bong Lee, Atheer Zgair, Tae Hwan Kim, Min Gi Kim, Sun Dong Yoo, Peter M. Fischer, Pavel Gershkovich · 2016 · Journal of Chromatography B
Chemotherapy and the Risk of Alzheimer's Disease in Colorectal Cancer Survivors: Evidence From the Medicare System
Akushevich, Igor, Yashkin, Arseniy P., Kravchenko, Julia, Kertai, Miklos D. · 2021 · JCO Oncology Practice
Bexarotene Improve Depression-Like Behaviour in Mice by Protecting Against Neuro-inflammation and Synaptic Damage
Chunling Yuan, Chunmei Dai, Ziqiang Li, Zheng Li, Miaoxin Zhao, Sumin Dong · 2020 · Neurochemical Research
New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes
Natalia N. Nalivaeva, Nikolai D. Belyaev, Anthony J. Turner · 2015 · Neurochemical Research
Spared Piriform Cortical Single-Unit Odor Processing and Odor Discrimination in the Tg2576 Mouse Model of Alzheimer's Disease
Wenjin Xu, Mirielle Lopez-Guzman, Chelsea B. Schoen, Shane M. Fitzgerald, Stephanie L. Lauer, Ralph A. Nixon, Efrat Levy, Donald A. Wilson · 2014 · PLoS ONE
Beta Amyloid Differently Modulate Nicotinic and Muscarinic Receptor Subtypes which Stimulate in vitro and in vivo the Release of Glycine in the Rat Hippocampus
Stefania Zappettini, Massimo Grilli, Guendalina Olivero, Elisa Mura, Stefania Preda, Stefano M. Govoni, Alessia Salamone, Mario Marchi · 2012 · Frontiers in Pharmacology
Evidence that an APOE ε4 'double whammy' increases risk for Alzheimer's disease
Ina Caesar, Sam Gandy · 2012 · BMC Medicine
Understanding the Role of miR-33 in Brain Lipid Metabolism: Implications for Alzheimer's Disease
Jaouen, Florence, Gascon, Eduardo · 2016 · The Journal of Neuroscience
Dual activities of the anti-cancer drug candidate PBI-05204 provide neuroprotection in brain slice models for neurodegenerative diseases and stroke
Michael J. Van Kanegan, Denise Dunn, Linda S. Kaltenbach, Bijal Dinesh Shah, He Dong, Daniel D. McCoy, Peiying Yang, Jiangnan Peng, Li Shen, Lin Du et al. · 2016 · Scientific Reports
Shared pathological pathways of Alzheimer's disease with specific comorbidities: current perspectives and interventions
Christiane M. Nday, Despoina Eleftheriadou, Graham Ellis Jackson · 2017 · Journal of Neurochemistry
Human Induced Pluripotent Stem Cell Models of Neurodegenerative Disorders for Studying the Biomedical Implications of Autophagy
Elena Seranova, Adina Maria Palhegyi, Surbhi Verma, Simona Dimova, Rachel Lasry, Moriyah Naama, Congxin Sun, Timothy Geoffrey Barrett, Tatiana Rosado Rosenstock, Dhiraj Kumar et al. · 2020 · Journal of Molecular Biology
The Nexus of Aβ, Aging, and Sleep
Jason R. Gerstner, Isaac J. Perron, Allan I Pack · 2012 · Science Translational Medicine
Deciphering the role of APOE in cerebral amyloid angiopathy: from genetic insights to therapeutic horizons
Hantian Hu, Siqi Wan, Yuetao Hu, Qi Wang, Hanyu Li, Nan Zhang · 2025 · Annals of Medicine
Unraveling the bidirectional link between cancer and dementia and the impact of cancer therapies on dementia risk: A systematic review and meta‐analysis
Liwei Ma, Edwin C.K. Tan, Benjamin Goudey, Liang Jin, Yijun Pan · 2025 · Alzheimer s & Dementia
Harnessing Nanochaperone‐Mediated Autophagy for Selective Clearance of Pathogenic Tau Protein in Alzheimer's Disease
Linlin Xu, Xiaohui Wu, Shuyue Zhao, Haodong Hu, Silei Wang, Yongxin Zhang, Jiajing Chen, Xiaochen Zhang, Yu Zhao, Rujiang Ma et al. · 2024 · Advanced Materials
Identification of Bexarotene as a PPAR γ Antagonist with HDX
David P. Marciano, Dana S. Kuruvilla, Bruce D. Pascal, Patrick R. Griffin · 2015 · PPAR Research
Targeting Retinoid Receptors to Treat Schizophrenia: Rationale and Progress to Date
Vladimir Lerner, Peter J. A. McCaffery, Michael S. Ritsner · 2016 · CNS Drugs
Sudden Intrabulbar Amyloid Increase Simultaneously Disrupts Olfactory Bulb Oscillations and Odor Detection
Rebeca Hernández‐Soto, Keila Dara Rojas-García, Fernando Peña‐Ortega · 2019 · Neural Plasticity
Frustrated peptide chains at the fibril tip control the kinetics of growth of amyloid-β fibrils
Yuechuan Xu, Kaitlin Knapp, Kyle N. Le, Nicholas P. Schafer, Mohammad S. Safari, Aram Davtyan, Peter Guy Wolynes, Peter G. Vekilov · 2021 · Proceedings of the National Academy of Sciences
In SilicoInvestigation of Traditional Chinese Medicine Compounds to Inhibit Human Histone Deacetylase 2 for Patients with Alzheimer’s Disease
Tzu-Chieh Hung, Wen‐Yuan Lee, Kuen‐Bao Chen, Yueh-Chiu Chan, Cheng-Chun Lee, Calvin Yu‐Chian Chen · 2014 · BioMed Research International
Indole Compound NC009-1 Augments APOE and TRKA in Alzheimer’s Disease Cell and Mouse Models for Neuroprotection and Cognitive Improvement
Yi-Chun Chen, Ya‐Jen Chiu, Chih‐Hsin Lin, Wen‐Chuin Hsu, Jia-Lu Wu, Chen-Hsiang Huang, Chia-Wei Lin, Ching‐Fa Yao, Hei-Jen Huang, Yen‐Shi Lo et al. · 2019 · Journal of Alzheimer s Disease
Current Drug Targets in Alzheimer’s Associated Memory Impairment: A Comprehensive Review
Chandrashekar K.S, Anna Mathew, Vignesh Balaji E, Karkala Sreedhara Ranganath Pai, Anoop Kishore, Vasudev Pai, Ramadevi Pemmireddy · 2022 · CNS & Neurological Disorders - Drug Targets
Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects
Yifan Yu, Shilong Yu, Giuseppe Battaglia, Xiaohe Tian · 2024 · Ibrain
Vasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and Interventions
Narayan R. Bhat · 2015 · Journal of Alzheimer s Disease
Genetic deletion of the H istone D eacetylase 6 exacerbates selected behavioral deficits in the R6/1 mouse model for Huntington's disease
Aliénor Ragot, Susanna Pietropaolo, Jean Didier Vincent, Pauline Delage, Hongyu Zhang, Bernadette Allinquant, Xavier Leinekugel, André Fischer, Yoon H. Cho · 2015 · Brain and Behavior
Chronic anti-murine Aβ immunization preserves odor guided behaviors in an Alzheimer's β-amyloidosis model
Daniel W. Wesson, José Morales‐Corraliza, Matthew J. Mazzella, Donald A. Wilson, Paul M. Mathews · 2012 · Behavioural Brain Research
A Novel Biphenyl-based Chemotype of Retinoid X Receptor Ligands Enables Subtype and Heterodimer Preferences
Julius Carl Pollinger, Simone Schierle, Leonie Gellrich, Julia Ohrndorf, Astrid Kaiser, Pascal Heitel, A. Chaikuad, Stefan Knapp, Daniel Merk · 2019 · ACS Medicinal Chemistry Letters
Age-Associated DNA Methylation Patterns Are Shared Between the Hippocampus and Peripheral Blood Cells
Christopher J. Harris, Brett A. Davis, Jonathan A. Zweig, Kimberly A. Nevonen, Joseph F. Quinn, Lucia Carbone, Nora E. Gray · 2020 · Frontiers in Genetics
Advances in Genetic and Molecular Understanding of Alzheimer’s Disease
Laura Ibáñez, Carlos Cruchaga, María Victoria Fernández · 2021 · Genes
Effects of polymorphisms in immunity-related genes on the immune system and successful aging
Qingwei Ruan, Feng Qian, Zhuowei Yu · 2014 · Current Opinion in Immunology
Assessment of Cognitive Phenotyping in Inbred, Genetically Modified Mice, and Transgenic Mouse Models of Alzheimer's Disease
Dong-Hee Kim, Yoon-Sun Jang, Won Kyung Jeon, Jung‐Soo Han · 2019 · Experimental Neurobiology
Molecular mechanisms of Alzheimer’s disease: From therapeutic targets to promising drugs
Alan, Elif, Kerry, Zeliha, Sevin, Gulnur · 2023 · Fundamental & Clinical Pharmacology
Endothelial genetic deletion of CD147 induces changes in the dual function of the blood‐brain barrier and is implicated in Alzheimer’s disease
Hao Wang, Jianjun Lv, Yu Zhao, Hao‐Lin Wei, Tianjiao Zhang, Hai‐Jiao Yang, Zhi‐Nan Chen, Jian‐Li Jiang · 2021 · CNS Neuroscience & Therapeutics
Revisiting APP secretases: an overview on the holistic effects of retinoic acid receptor stimulation in APP processing
José J. M. Vitória, Diogo Trigo, Odete A. B. da Cruz e Silva · 2022 · Cellular and Molecular Life Sciences
Aerobic Exercise Facilitates the Nuclear Translocation of SREBP2 by Activating AKT/SEC24D to Contribute Cholesterol Homeostasis for Improving Cognition in APP/PS1 Mice
Zelin Hu, Yang-Qi Yuan, Zhen Tong, Meiqing Liao, Shunling Yuan, Weijia Wu, Yingzhe Tang, Yirong Wang, Chenhao Tang, Wenfeng Liu · 2023 · International Journal of Molecular Sciences
Potential repurposing of oncology drugs for the treatment of Alzheimer's disease
Wataru Araki · 2013 · BMC Medicine
Inhibition of brain retinoic acid catabolism: a mechanism for minocycline's pleiotropic actions?
Francesca Regen, Nathalie Le Bret, Martin Hildebrand, Irmelin Herzog, Isabella Heuser, Julian Hellmann‐Regen · 2015 · The World Journal of Biological Psychiatry
Human Apolipoprotein E Genotype Differentially Affects Olfactory Behavior and Sensory Physiology in Mice
Brett S. East, Gloria Fleming, Kathy Peng, Jonas Olofsson, Efrat Levy, Paul M. Mathews, Donald A. Wilson · 2018 · Neuroscience
Retinoid X Receptor Alpha Nitro-ligand Z-10 and Its Optimized Derivative Z-36 Reduce β-Amyloid Plaques in Alzheimer’s Disease Mouse Model
Gaoang Ren, Wei Bao, Zhiping Zeng, Weidong Zhang, Ce Shang, Maosi Wang, Ying Su, Xiao-kun Zhang, Hu Zhou · 2018 · Molecular Pharmaceutics
Competitive Binding Assay with an Umbelliferone-Based Fluorescent Rexinoid for Retinoid X Receptor Ligand Screening
Shoya Yamada, Mayu Kawasaki, Michiko Fujihara, Masaki Watanabe, Yuta Takamura, Maho Takioku, Hiromi Nishioka, Yasuo Takeuchi, Makoto Makishima, Tomoharu Motoyama et al. · 2019 · Journal of Medicinal Chemistry
Genomic background-related activation of microglia and reduced β-amyloidosis in a mouse model of Alzheimer's disease
Christina Fröhlich, Kristin Paarmann, Johannes Steffen, Jan Stenzel, Markus Krohn, Hans‐Jochen Heinze, Jens Pahnke · 2013 · European Journal of Microbiology and Immunology
Synthesis and biological evaluation of halogenated curcumin analogs as potential nuclear receptor selective agonists
Shane F. Batie, Jamie H. Lee, Rabia A. Jama, Drew O. Browder, Luis A. Montano, Chanh C. Huynh, Lisa M. Marcus, Dorian G. Tsosie, Zeynab Mohammed, Vu Trang et al. · 2012 · Bioorganic & Medicinal Chemistry
Cocaine Induces Nuclear Export and Degradation of Neuronal Retinoid X Receptor-γ via a TNF-α/JNK- Mediated Mechanism
Jane Kovalevich, William Yen, Ahmet Y. Ozdemir, Dianne Langford · 2015 · Journal of Neuroimmune Pharmacology
Neuroprotective effect of naturally occurring RXR agonists isolated from Sophora tonkinensis Gagnep. on amyloid-β-induced cytotoxicity in PC12 cells
Wei Wang, Ken‐ichi Nakashima, Takao Hirai, Makoto Inoue · 2018 · Journal of Natural Medicines
APOE Lipoprotein Particles: Pathophysiology, Therapy, and the Crosstalk in Alzheimer’s Disease and Cardiovascular Disease
Чан Лю, Juan Liu, Yanyang Wang, Shang-Fu Xu, Li-Mei Yu · 2025 · Molecular Neurobiology
Association between polymorphisms in the promoter region of the apolipoprotein E (APOE) gene and Alzheimer’s disease: a meta-analysis
Xiao, Hanyan, Yifeng Gao, Lei Liu, Yan Li · 2017 · EXCLI journal
The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer
Ana S. Leal, Jessica A. Moerland, Di Zhang, Sarah Carapellucci, Beth Lockwood, Teresa Krieger-Burke, Bilal Aleiwi, Edmund L. Ellsworth, Karen T. Liby · 2021 · Cancers
Reflections of a Pessimistic Gerontologist or Why We Still Do Not Live 1000 Years
Alexander N. Khokhlov · 2021 · Moscow University Biological Sciences Bulletin
Key brain cell interactions and contributions to the pathogenesis of Alzheimer’s disease
Joana Saavedra, Mariana Nascimento, Márcia A. Liz, Isabel Cardoso · 2022 · Frontiers in Cell and Developmental Biology
A novel apoE-mimetic increases brain apoE levels, reduces Aβ pathology and improves memory when treated before onset of pathology in male mice that express APOE3
Ana Carolina Valencia‐Olvera, Deebika Balu, Shreya Bellur, Thomas P. McNally, Yaseen Saleh, Don Pham, Shivesh Ghura, Jason M. York, Jan O. Johansson, Mary Jo LaDu et al. · 2023 · Alzheimer s Research & Therapy
When the dust settles: what did we learn from the bexarotene discussion?
Ina C. Tesseur, Bart De Strooper · 2013 · Alzheimer s Research & Therapy
Identification of approved drugs that inhibit the binding of amyloid β oligomers to ephrin type‐B receptor 2
Koichiro Suzuki, Takahiro Aimi, Tomoaki Ishihara, Tohru Mizushima · 2016 · FEBS Open Bio
Pharmacogenetics and Pharmacotherapy of Military Personnel Suffering from Post-traumatic Stress Disorder
Janine Naß, Thomas Efferth · 2016 · Current Neuropharmacology
Synthesis of 11C-Labeled RXR Partial Agonist 1-[(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)amino]benzotriazole-5-carboxylic Acid (CBt-PMN) by Direct [11C]Carbon Dioxide Fixation via Organolithiation of Trialkyltin Precursor and PET Imaging Thereof
Osamu Shibahara, Masaki Watanabe, Shoya Yamada, Masaru Akehi, Takanori Sasaki, Akiya Akahoshi, Takahisa Hanada, Hiroyuki Hirano, Shunsuke Nakatani, Hiromi Nishioka et al. · 2017 · Journal of Medicinal Chemistry
Bexarotene attenuates early brain injury via inhibiting micoglia activation through PPARγ after experimental subarachnoid hemorrhage
Li Tu, Xiulin Yang, Qian Zhang, Qian Wang, Tian Tian, Dan Liu, Xiang Qu, Jinyong Tian · 2018 · Neurological Research
Design and synthesis of thymine modified phthalocyanine for Aβ protofibrils photodegradation and Aβ peptide aggregation inhibition
Qichen Zhan, Xianqing Shi, Ting Wang, Jinhui Hu, Jiahong Zhou, Lin Zhou, Shaohua Wei · 2018 · Talanta
Bexarotene Impairs Cognition and Produces Hypothyroidism in a Mouse Model of Down Syndrome and Alzheimer’s Disease
Verónica Vidal, A. Puente, Susana García-Cerro, M. T. García Unzueta, N. Rueda, J. Riancho, C. Martínez-Cué · 2021 · Frontiers in Pharmacology
Liver X receptor agonist T0901317 reduces neuropathological changes and improves memory in mouse models of experimental dementia
Rupinder Kaur Sodhi, Nirmal Singh · 2014 · European Journal of Pharmacology
Synthesis, kinetic studies and molecular modeling of novel tacrine dimers as cholinesterase inhibitors
Roney Anderson Nascimento de Aquino, Luzia V. Modolo, Rosemeire B. Alves, Ângelo de Fátima · 2013 · Organic & Biomolecular Chemistry
Discovery of PET radiopharmaceuticals at the academia-industry interface
Vadim Bernard‐Gauthier, Thomas Lee Collier, Steven H. Liang, Neil Vasdev · 2017 · Drug Discovery Today Technologies
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John Holmes Miller, Alladi Charanraj Goud, Narendran Annadurai, Juan Bautista De Sanctis, Lenka Hrubá, Marián Hajdúch · 2024 · Medicinal Research Reviews
Dual-targeting tigecycline nanoparticles for treating intracranial infections caused by multidrug-resistant Acinetobacter baumannii
Xing Lan, Shugang Qin, Huan Liu, Mengran Guo, Yupei Zhang, Xinyang Jin, Xing Duan, Min Sun, Zhenjun Liu, Wenyan Wang et al. · 2024 · Journal of Nanobiotechnology
Bexarotene prodrugs: Targeting through cleavage by NQO1 (DT-diaphorase)
Anja Schäfer, Ethan S. Burstein, Roger Olsson · 2014 · Bioorganic & Medicinal Chemistry Letters
Alzheimer′s disease: Unique markers for diagnosis & new treatment modalities
Neelum T. Aggarwal, Raj C. Shah, David A. Bennett · 2015 · The Indian Journal of Medical Research
Differential Binding of Human ApoE Isoforms to Insulin Receptor is Associated with Aberrant Insulin Signaling in AD Brain Samples
Elizabeth S. Chan, Christopher Chen, Tuck Wah Soong, Boon‐Seng Wong · 2018 · NeuroMolecular Medicine
Bexarotene Binds to the Amyloid Precursor Protein Transmembrane Domain, Alters Its α-Helical Conformation, and Inhibits γ-Secretase Nonselectively in Liposomes
Frits Kamp, Holger A. Scheidt, Edith Winkler, Gabriele Basset, Hannes Heinel, J.M.S. Hutchison, Loren M. LaPointe, Charles R. Sanders, Harald Steiner, Daniel Huster · 2018 · ACS Chemical Neuroscience